²é¿´: 686  |  »Ø¸´: 7
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

uracil

ľ³æ (ÕýʽдÊÖ)

[½»Á÷] [Topic-01]ÄÉÃ×¼¼ÊõÔÚÈÕ»¯ÐÐÒµÖеÄÓ¦ÓÃ

ÄÉÃ×¼¼ÊõµÄÓ¦ÓÃÈÕÒæ¹ã·º
¾ßÌåµ½ÔÚÈÕ»¯ÐÐÒµÖУ¬ÄÉÃ×¼¼ÊõÔÚ·Àɹ¼ÁµÈ·½ÃæÒѽøÈëʵ¼ÊÓ¦Óý׶Î
Ϊ¸ú×ÙÐÐÒµ¶¯Ì¬£¬±¾°æÕ÷¼¯Ïà¹ØÓ¦ÓÃÊÂÀý¼°×ÊÔ´
[¿É½«Á´½á±à¼­µ½±¾ÌùÏÂÃæ£¬Ö÷ÌâÄÚÈÝ£¬¿ÉпªÌù·¢²¼]


£¨1£©¶ÔÌṩÓÐЧ×ÊÔ´µÄ³æ×Ó£¬¸øÓèÿÌû²»µÍÓÚÈý¸ö½ð±ÒµÄ½±Àø£¡

£¨2£©¶ÔÓÚ¼ÈÄܹ»ÌṩÓÐЧ×ÊÔ´£¬ÓÖÄܹ»ÒýÆðÈÈÁÒÌÖÂÛµÄÌû×Ó£¬½ð±Ò½±Àø¶î¶È¼Ó´ó¡£



ͬʱ»ý¼«»¶Ó­ÄúΪÈÕ»¯°æ¿éµÄ·¢Õ¹°ÑÂö....

http://muchong.com/bbs/viewthread.php?tid=514820&fpage=1

[ Last edited by berlin on 2007-6-30 at 02:17 ]
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

macromol

Òø³æ (СÓÐÃûÆø)

¹â¿ª¹ØÓ«¹âÄÉÃ׿ÅÁ£ÔÚ¿ÉÄæ×ÏÍâ/¿É¼û¹âÕÕÉäϵķÀ»¤×÷ÓÃ

¡ï
berlin(½ð±Ò+1):Èç¹ûÄܹ»¾ÍÕâÆªÎÄÕÂÏêϸµÄ˵˵ÄúµÄ¶Áºó¸Ð£¬ÄúµÄ½ð±Ò»á³É±¶µÄÔö³¤°Â£¬ºÇºÇ
¹â¿ª¹ØÓ«¹âÄÉÃ׿ÅÁ£ÔÚ¿ÉÄæ×ÏÍâ/¿É¼û¹âÕÕÉäϵķÀ»¤×÷ÓÃ
ÔÚÄÉÃ׿ÅÁ£Öй⿪¹Ø·Ö×Ó²»½ö¿ÉÒÔ¾ßÓпÉÄæÐÔ£¬»¹·¢Ó«¹â¡£±È½ÏÓÐÒâ˼¡£
JACS 2007 128 4303
5Â¥2007-06-29 22:25:01
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 8 ¸ö»Ø´ð

zhjf

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)

ÓÅÐã°æÖ÷

ºÜºÃµÄ½¨Ò飬ÔõôûÈ˶¥£¡
2Â¥2007-06-13 11:33:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhjf

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)

ÓÅÐã°æÖ÷

·Àɹ»¯×±Æ·ÖеÄÄÉÃ×¼¼Êõ

¡ï ¡ï ¡ï ¡ï ¡ï
berlin(½ð±Ò+5):½ð±ÒÀ´³Ù£¬ÐÖµÜÎð¹Ö£¬»¶Ó­Äã²ÎÓëµ½ÈÕ»¯°æ¿éµÄ½¨ÉèÖÐÀ´
¹ýÁ¿µÄ×ÏÍâÏßÕÕÉä¿ÉÒÔÔö¼ÓƤ·ô¶ñÐÔÖ×ÁöµÄ·¢²¡ÂʺͼÓËÙÆ¤·ôµÄ¹âÀÏ»¯£¬½üÄêÀ´,Ëæ×ÅÈËÃǶÔ×ÏÍâÏßÈÏʶµÄÌá¸ß¼°±£½¡ÒâʶµÄÔöÇ¿,·ÀɹÐÍ»¯×±Æ·µÄ¿ª·¢¡¢Ó¦ÓÃÖð½¥³ÉΪһ¸ö¿ÆÑÐÈȵ㡣ÄÉÃ×¼¼ÊõÕâÏîм¼Êõ¸øÐÂÐÍ¡¢ÓÅÖÊ·Àɹ¼ÁÑо¿ºÍ¿ª·¢´øÀ´ÁËÓÕÈ˵Äǰ¾°£¬ÄÉÃ×»¯×±Æ·ÔÚ»îÐԳɷֺÍÔØÌåÁ½·½ÃæµÄ¹Ø¼ü¼¼ÊõÖгä·ÖÌåÏÖÁËÆäÓÅÔ½ÐÔ£¬µ«Ó¦ÓÃʱ»¹Ðè×¢ÒâһЩÎÊÌ⣬Æä°²È«ÐÔÈÔÓдý½øÒ»²½Ñо¿¡£

1  ·Àɹ»¯×±Æ·
    ·Àɹ»¯×±Æ·ÊôÓÚ»¯×±Æ··ÖÀàÖеÄÌØÊâÓÃ;À࣬·Àɹ»¯×±Æ·Åä·½Öк¬ÓÐÒ»¶¨Á¿µÄ·Àɹ¼Á£¬·Àɹ¼ÁÄܹ»±£»¤Æ¤·ôÃâÊÜ×ÏÍâÏßÉ˺¦£¬ÊǾßÓÐÒ»¶¨·Àɹ¹¦ÄܵĻ¯×±Æ·¡£  
1.1·Àɹ»¯×±Æ·µÄ·¢Õ¹Ç÷ÊÆ£º¹ú¼ÊÉÏÔÚ20ÊÀ¼Í50Äê´úÒÑ¿ªÊ¼¹ã·ºÊ¹Ó÷Àɹ»¯×±Æ·£¬ÔÚ½ü20ÄêÀ´·Àɹ»¯×±Æ·µÄÉú²ú°üÀ¨Æ·ÖÖºÍÖÊÁ¿¶¼µÃµ½Á˾ªÈ˵ķ¢Õ¹[1]¡£·Àɹ¼ÁÒ²³ÆÕÚ¹â¼Á£¬°´Æä·À»¤×÷ÓûúÖÆ¿É·ÖΪÎïÀí×èµ²¼ÁºÍ»¯Ñ§ÎüÊÕ¼Á¡£Ä¿Ç°,¹úÄÚ×î³£ÓõķÀɹ¼ÁÓм×Ñõ»ùÈâ¹ðËáÐÁõ¥µÈÓлú·Àɹ¼Á(ÊôÓÚ»¯Ñ§·Àɹ¼Á) ºÍ¶þÑõ»¯îÑ¡¢Ñõ»¯Ð¿¡¢Ñõ»¯¹èµÈÎÞ»ú·Àɹ¼Á(ÊôÓÚÎïÀí·Àɹ¼Á)¡£ÎïÀí×èµ²¼Áͨ¹ýÆä¶Ô×ÏÍâÏߵķ´Éä»òÕßÉ¢Éä¶ÔƤ·ôÆðÆÁ±Î×÷Ó㬴Ӷø´ïµ½·ÀɹЧ¹û¡£»¯Ñ§ÎüÊÕ¼ÁÖ÷ÒªÎüÊÕʹƤ·ô²úÉúºì°ßµÄÖв¨×ÏÍâÏߣ¨Ultraviolet B ,UVB£© ,²¿·ÖÒ²ÎüÊÕʹƤ·ô±äºÚµÄ³¤²¨×ÏÍâÏߣ¨Ultraviolet A ,UVA£©£¬´Ó¶ø·ÀֹƤ·ôɹºì»ò²úÉúºÚ°ß¡£ÐÂÐÍ´ó·Ö×Ó»ò¸ß·Ö×Ó×ÏÍâÏßÎüÊÕ¼Á¡¢·ÂÉú·Àɹ¼Á¡¢ÌìÈ»·Àɹ¼ÁµÈ½«Êǽñºó·Àɹ»¯×±Æ·µÄ·¢Õ¹Ç÷ÊÆ¡£
1.2 ·Àɹ»¯×±Æ·µÄÖØÒªÐÔ£º×ÏÍâÏß·ÖΪ¶Ì²¨×ÏÍâÏߣ¨Ultraviolet C ,UVC£©(200¡«280 nm)¡¢Öв¨×ÏÍâÏßUVB (280¡«320nm)ºÍ³¤²¨×ÏÍâÏßUVA (320¡«400 nm) [2]£¬ÌìÈ»»òÈ˹¤µÄ×ÏÍâÏßÕÕÉä²»½öÄܶÔÈËµÄÆ¤·ô´øÀ´½¡¿µ»¹ÄÜ´øÀ´ËðÉË¡£¹ýÁ¿µÄ×ÏÍâÏßÕÕÉäÌáʾƤ·ô¶ñÐÔÖ×Áö·¢²¡ÂÊÔö¼Ó²¢¼ÓËÙÆ¤·ô¹âÀÏ»¯[3]¡£Òò´Ë£¬Æ¤·ôÐèÒª³ä·ÖµÄ±£»¤£¬·Àɹ¼ÁÄÜ´ïµ½Õâ¸ö±£»¤Ä¿µÄ¡£¾ÝTsukahara,MoriwakiµÈ[4]±¨µÀ£¬·Àɹ¼ÁµÄÓ¦ÓÃÄÜÔ¤·À¶¯ÎïÄ£ÐͺÍÈËÆ¤·ôµÄ¹âÀÏ»¯¡£·Àɹ¼Á¿ÉÒÔÒÖÖÆÆ¤·ôµ¯ÐÔø»îÐÔ£¬¼õÇá¹âÀÏ»¯£¬ÁíÍâÒòΪ¹ýÁ¿µÄ×ÏÍâÏß±©Â¶ÊǺÚÉ«ËØÁöºÍ·ÇºÚÉ«ËØÁöµÄÖ÷ÒªÔ­Òò¡£AzzarelloµÈ[5]ÍÆ¼ö³£¹æÊ¹Ó÷Àɹ¼ÁÀ´Ô¤·ÀƤ·ô°©¡£Æ¤·ô°©Ô¤·À¶Ô¸ß·çÏÕ¸öÈËÀ´ËµÓÈÆäÖØÒª£¬ ±ÈÈç˵¾ßÓкÚÉ«ËØÁö¼Ò×åÊ·µÄÈË£¬ÆäƤ·ôÐèÒª³ä·ÖµÄ¹â±£»¤¡£DraelosµÈ[6]Ñо¿Ö¤Ã÷ë·¢µÄ¹â±£»¤ÊÇά³Öë¸É²¿·ÖÃÀÈݼÛÖµµÄÖØÒª²¿·Ö¡£Èç¹ûÈÃÍ··¢ÆØÉ¹ÔÚÑô¹âÏ£¬¹ýÁ¿µÄ×ÏÍâÏß»áÆÆ»µ´æÔÚÓÚÍ··¢Æ¤ÖʲãÖеĺÚËØ£¬Ê¹Í··¢ÍÊÉ«£¬±äµÃ¿Ý»Æ¡£´ËÍ⣬×ÏÍâÏß»¹»áÆÆ»µÍ··¢ÏËάÖеĵ°°×ÖÊ£¬Ê¹Í··¢¹ýÔçµÄÀÏ»¯¡£ÊÐÃæÉϺܶàÃÀ·¢ÓÃÆ·±êÓÐÁ½ÖÖ·ÀɹָÊý¼´·ÀɹָÊý£¨Sun Protection Factor £¬SPF£©ºÍ½Çµ°°×·À»¤Ö¸Êý£¨Keratin Protection Factor£¬KPF£©£¬Ç°ÕßÊÇÖ¸¶ÔͷƤ²ãµÄ±£»¤³Ì¶È£¬¶øºóÕßÊÇרÃÅÕë¶Ô·¢¸ÉµÄ±£»¤Ö¸Êý¡£
  
2  ÄÉÃ×¼¼ÊõÔÚ·Àɹ»¯×±Æ·ÖеÄÓ¦ÓÃ
    ÄÉÃ×·Àɹ»¯×±Æ·ÊDzÉÓÃÄÉÃ×¼¼ÊõÑÐÖÆµÄ·Àɹ»¯×±Æ·£¬Ëü½«·Àɹ»¯×±Æ·ÖеĻîÐԳɷÖÌØÊâ´¦Àí³ÉÄÉÃ×¼¶ÕâÖÖ¼«Æä΢СµÄ½á¹¹£¬²¢½áºÏʹÓø÷ÖÖÐÂÐÍÄÉÃ×ÔØÌåϵͳ£¬Ê¹·ÀɹЧ¹û´ó´óÔöÇ¿ÇÒ¾ßÓÐһЩÐÂÆæµÄÌØÐÔ¡£
2.1 ÄÉÃ׵ĸÅÄîÒÔ¼°ÄÉÃײÄÁϵÄÓÃ;£ºÄÉÃ×(nanometer , nm) ÊÇÒ»ÖÖ³¤¶È¼ÆÁ¿µ¥Î»[7]¡£ÄÉÃ×¼¼ÊõÊÇÖ¸ÔÚ0¡«100nm³ß¶È·¶Î§ÄÚ,ÔÚÔ­×ӺͷÖ×ÓˮƽÉϲÙ×ÝÎïÖÊ£¬Ê¹ÆäÖØÐÂÅÅÁÐ×éºÏ£¬ÐγÉеľßÓÐÄÉÃ׳߶ȵÄÎïÖÊ»òÕ߽ṹ£¬½øÒ»²½Ñо¿ÆäÌØÐÔ£¬²¢ÓÉ´ËÖÆÔì³ö¾ßÓÐй¦Äܵį÷¼þ¡¢²ÄÁÏÒÔ¼°¿ÉÓ¦ÓÃÓÚÆäËû¸÷¸ö·½ÃæµÄ¿ÆÑ§·½·¨[8]¡£ÓÉÓÚÄÉÃ׿ÅÁ£±íÃæÓзdz£¸ßµÄÀí»¯»îÐÔ, Òò¶øÎïÖÊÔÚÄÉÃ׳߶ÈÏ»ᷢÉú·±¶àµÄ±ä»¯, ÄÉÃײÄÁϻᷢÉúÌØÊâµÄ¹âµçѧ¡¢ÈÈÁ¦Ñ§¼°µç´ÅѧµÈÆæÌØµÄÐÔÖÊ, ¿ÉÀûÓÃÆä¶ÀÌØµÄ»îÐÔ, Ó¦ÓÃÓÚ¸÷¸ö¿ÆÑ§ÁìÓòÄÚ¡£Ò©Ñ§µÄ·¢Õ¹¡¢DNA»ùÒòÖÎÁÆÖеÄϸ°ûתȾ¡¢ÐµÄҽѧӰÏñÓõÄÕï¶ÏÊÔ¼ÁÈ糬˳´ÅÐÔÈýÑõ»¯Ìú£¨superparamagnetic iron oxides £¬SPIOs£©¡¢ÉúÎï·ÖÎö¡¢¿ÉÖÃÈëµÄ¼ÙÌå×°ÖúÍÄÉÃ×Ö§¼ÜµÈÈ˹¤Æ÷¹ÙµÄ·¢Õ¹µÈ¶¼ÊÇÄÉÃ×¼¼ÊõÔÚÁÙ´²·½ÃæµÄÓÐЧÀýÖ¤[9]¡£
2.2ÄÉÃ×¼¼ÊõÔÚ·Àɹ»¯×±Æ·ÖÐÓ¦ÓõÄÓÅÔ½ÐÔ£º·Àɹ¼ÁµÄÑ¡ÔñÊÇ·Àɹ»¯×±Æ·Åä·½µÄºËÐÄËùÔÚ¡£´«Í³µÄ·Àɹ»¯×±Æ·ÍùÍùʹÓÃÓлú»¯ºÏÎï×÷Ϊ×ÏÍâÎüÊÕ¼Á,µ«ÊÇ,ΪÁ˾¡¿ÉÄܱ£»¤Æ¤·ô²»½Ó´¥×ÏÍâÏß,±ØÐëÌá¸ßÆäÌí¼ÓÁ¿,¶øÕâÑù¾Í»áÔö¼Ó²úÆ·³É±¾£¬½µµÍ²úÆ·µÄ°²È«ÐÔ¡£Ó봫ͳµÄ·Àɹ»¯×±Æ·Ïà±ÈÄÉÃ×·Àɹ»¯×±Æ·ÓÐÏÔÖøµÄÓÅÔ½ÐÔ£¬ÌåÏÖÔÚÒÔϼ¸¸ö·½Ã棺¢Ù¸üÇ¿µÄ·ÀɹÐÔÄÜ£º½«¶þÑõ»¯îѼ°Ñõ»¯Ð¿ÄÉÃ×»¯¡¢³¬Ï¸»¯£¬ÔÚ·ÛÌå±íÃæ°ü¸²¾ßÓÐÇ×Ë®¡¢Ç×Ó͹¦ÄÜ»ùÍŵıíÃæ»¯´¦Àí£¬ÒÔ´ËÌá¸ß·ÛÌåµÄÊÊÅäÐÔÒÔ¼°ÔÚ²»½µµÍ͸Ã÷¶ÈµÄÇé¿öÏÂÏÔÖøÌá¸ßÁ½ÕßµÄUVA ÆÁ±ÎЧ¹û£»¢Ú½ÏÈõµÄ´Ì¼¤ÐÔ£º´«Í³µÄÓлú·Àɹ¼Á»îÐԺʹ̼¤ÐÔ½ÏÇ¿£¬»á¶ÔƤ·ô²úÉú¶¾¸±×÷Ó㬶øÄÉÃ×ÎÞ»ú²ÄÁϿ˷þÁË´«Í³Åä·½µÄȱµã£¬Ó¦Ó÷dz£°²È« [10]£»¢ÛÁ¼ºÃµÄ¹âÎȶ¨ÐÔ¡¢ÄÍÈÈÐÔ£ºÓлú×ÏÍâÏßÎüÊÕ¼ÁÓÐÐí¶àÔÚ¸ßÎÂ״̬ÏÂʹÓûá³öÏÖ»Ó·¢»ò·Ö½âÎÊÌâ,µ«ÄÉÃ×Ñõ»¯Ð¿¶ÔÈȷdz£Îȶ¨£»¢ÜÎȶ¨µÄÄÉÃ×°ü¹ü¼¼Êõ£ºÄ¿Ç°·Àɹ»¯×±Æ·ÖжàʹÓø´ºÏ·Àɹ¼Á,²ÉÓÃÄÉÃ×¼¼Êõ½«¶àÖÖ·Àɹ¼Á°ü¹üÔÚÄÉÃ×΢ÇòÖÐ,ÕâÑù¿ÉÒÔÓÅ»¯¶àÖÖ·Àɹ¼ÁµÄÐÔÄÜ, ʹÆäÅä·½Îȶ¨£¬ÓÐЧ»îÐԳɷֱ£´æÊ±¼ä¾Ã£¬Ð§¹û±¶Ôö£¬´ËÍ⣬»¹¿ÉÒÔÓпØÖƵØÊÍ·ÅÓÐЧ»îÐԳɷ֣¬ÏÔÖøÌá¸ß²úÆ·µÄSPFÖµ¡£

3  ÄÉÃ×¼¼ÊõÔÚ·Àɹ»¯×±Æ·ÖÐÓ¦ÓõĹؼü  
3.1 »îÐԳɷ֣ºÑõ»¯Ð¿¡¢¶þÑõ»¯îÑ¡¢»¬Ê¯·Û¡¢¸ßÁëÍÁµÈÎÞ»ú·ÛÄ©ÊÇĿǰÎïÀí·Àɹ¼ÁµÄ³£Óóɷ֡£ÆäÖÐÒÔÄÉÃ×¼¶Ñõ»¯Ð¿ºÍÄÉÃ×¶þÑõ»¯îÑЧ¹ûΪ×îºÃ¡£ÄÉÃ×Ñõ»¯Ð¿¿É²ÉÓùÌÏà·´Ó¦- ¸ßÎÂÈȽⷨ¡¢¾ùÔȳÁµí·¨µÈ·½·¨À´ÖƱ¸µÃµ½ [11]£¬Ñõ»¯Ð¿ÄÉÃ×»¯ºóͬʱ¾ßÓÐÄÉÃײÄÁϺʹ«Í³Ñõ»¯Ð¿µÄË«ÖØÌØÐÔ£º¢ÙÓ봫ͳÑõ»¯Ð¿²úÆ·Ïà±È£¬±ÈÆä±íÃæ»ý£¨±íÃæ»ý£¯Ìå»ý£©´ó¡¢»¯Ñ§»îÐԸߣ¬²úƷϸ¶È¡¢»¯Ñ§´¿¶ÈºÍÁ£×ÓÐÎ×´¿ÉÒÔ¸ù¾ÝÐèÒª½øÐе÷Õû£¬²¢ÇÒ¾ßÓй⻯ѧЧӦºÍ½ÏºÃµÄÕÚ±Î×ÏÍâÏßÐÔÄÜ£¬Æä×ÏÍâÏßÕÚ±ÎÂʸߴï98%£¬Äܹ»ÌṩUVAºÍUVBÈ«²¨¶ÎµÄÓÐЧ·À»¤ [12]£»¢ÚËü»¹¾ßÓп¹¾úÒÖ¾ú¡¢ìîζ·ÀùµÈһϵÁжÀÌØÐÔÄÜ£¬Óйص͍Á¿ÊÔÑé±íÃ÷ÄÉÃ×Ñõ»¯Ð¿µÄÖÊÁ¿·ÖÊýΪ1%ʱ, ÔÚ5 minÄÚ¶Ô½ð»ÆÉ«ÆÏÌÑÇò¾úµÄɱ¾úÂÊΪ98.86 %, ¶Ô´ó³¦¸Ë¾úµÄɱ¾úÂÊΪ99.93£¥ [13]£»¢ÛÄÉÃ×Ñõ»¯Ð¿¾ßÓÐÓÅÒì·ÖÉ¢ÐÔºÍ͸Ã÷ÐÔ£¬Ëü²»ÎüÊÕ¿ÉÊÓ¹âÏß,ÇÒÕÛÉäÂʺܵÍ,²¢¼õµÍ¹âµÄÉ¢Éä,µÃµ½ÎÞɫ͸Ã÷ÐԸߵÄЧ¹û¡£´ËÍ⣬Æä΢Á£½á¾§ÐÔÄܸß,¼´Ê¹ÔÚ¿ÕÆøÖлò¸÷ÖÖÈÜýÖÐÒ²Óм«ÓÅÐãµÄ·ÖÉ¢ÐÔ[14]¡£
3.2 ÔØÌ壺ÐÂÐÍÔØÌåÔÚ·Àɹ»¯×±Æ·µÄ»îÐÔ´«Êä¼¼ÊõÖкܹؼü£¬ÔØÌåµÄ²»Í¬Ö±½ÓÓ°Ïì·Àɹ¼ÁµÄÐÔÄÜ¡£ÄÉÃ×¼¼ÊõµÄ·¢Õ¹´øÀ´Á˶àÖÖÐÂÐÍÔØÌåϵͳÈçÄÉÃ׿ÅÁ£Ðü¸¡Òº¡¢Ö¬ÖÊÌå¡¢¹ÌÌåÖ¬ÖÊÄÉÃ×Á£¡¢ÄÉÃ׽ṹ֬ÖÊÔØÌå¡¢ÄÉÃ×ÈéÒº¡¢¾ÛºÏÎïÄÉÃ×Á£¡¢´ÅÐÔÄÉÃ×ÔØÌå¼°ÎÞ»ú²ÄÁÏÄÉÃ×ÔØÌåµÈ£¬ÔÚ·Àɹ»¯×±Æ·ÖÐÓ¦Óý϶àµÄÊǹÌÌåÖ¬ÖÊÄÉÃ×Á££¨solid lipid nanoparticles £¬SLN£©£¬ËüÊÇ20ÊÀ¼Í90Äê´ú·¢Õ¹ÆðÀ´µÄÒ»ÖÖÐÂÐÍ΢Á£ÔØÌåϵͳ¡£SLNÒÔÌìÈ»»òºÏ³ÉµÄ¹Ì̬ÀàÖ¬ÎªÔØÌ壬½«Ò©Îï»ò»îÐԳɷְü¹üÓÚÀàÖ¬µÄºËÖУ¬ÖƳÉÁ£¾¶Îª50¡«1000 nmµÄÄÉÃ×ÔØÌåϵͳ¡£SylviaµÈ[15]±¨µÀSLN¿ÉÒÔ×÷ΪÃÀÈÝ»îÐԳɷָ»ÓÐǰ¾°µÄÔØÌ壬ÒòΪËüÓë´«Í³ÔØÌåÏà±ÈÓкܶàÓŵ㣺¢ÙSLN¿ÉÒÔ±£»¤²»Îȶ¨»¯ºÏÎïÒÔ¼õÉÙÆä»¯Ñ§½µ½â£¬ÈçάÉúËØA¡¢E; ¢Ú¸ù¾ÝÉú²úµÄSLNÀàÐÍ¿ØÖÆ»îÐÔÎïÖʵÄÊÍ·Å¡£È罫»îÐԳɷָ½ÓÚSLNµÄÍâ¿Ç¾Í¾ßÓÐÁ¢¼´ÊͷŵÄÌØÐÔ£¬¶ø½«»îÐԳɷÖÖÃÓÚÖ¬ÖÊÌåµÄºËÐÄÔò¿ÉÒÔ¿ØÖÆÆä³ÖÐøÊÍ·Å;¢ÛSLN×÷Ϊ·â°ü¼Á£¬¿ÉÒÔÓÃÀ´Ôö¼ÓƤ·ôµÄË®ºÏ×÷ÓÃ;¢ÜSLNÓÐ×èµ²×ÏÍâÏßµÄDZÄÜ£¬±¾Éí¿ÉÒÔ×÷ΪÎïÀí·Àɹ¼Á£¬Ò²ÄÜºÍÆäËû·Ö×Ó·Àɹ¼ÁÁªºÏʹÓûñµÃ¸üºÃµÄ¹â±£»¤Ð§¹û ¡£Ò»¸ö»îÌåʵÑéÑо¿±íÃ÷ÔÚ´«Í³µÄO/W¼ÁÐÍÖмÓÉÏ4%µÄSLN £¬Ê¹ÓÃ4Öܺó¿ÉÒÔʹƤ·ôµÄË®ºÏ×÷ÓÃÌá¸ß31%¡£¶øSLN×÷ΪÎïÀí·Àɹ¼ÁºÍ·Ö×Ó·Àɹ¼ÁµÄ»îÐÔÔØÌåÑо¿±íÃ÷£¬·Ö×Ó·Àɹ¼ÁµÄÁ¿¼õÉÙ50%ʱ¾Í¿ÉÒÔ´ïµ½´«Í³·Àɹ¼ÁµÄͬµÈЧ¹û¡£Song [16]ÔÚ2005ÄêÒ²±¨µÀÁËÔØÓÐ3£¬4£¬5-Èý¼×Ñõ»ù±½õ£½ÇËØ£¨3,4,5-trimethoxybenzoylchitin£¬TMBC£©µÄSLN£¬±¾Éí¼È¿ÉÒÔ×÷ΪÎïÀí·Àɹ¼Á£¬ÓÖ×÷ÎªÔØÌå´Ù½ø¶ÔUVBµÄ±£»¤¡£ÁíÍâ΢½ºÄÒÊÇÖ¸ÓþۺÏÎﱡĤ½«Î¢Á¿¹ÌÌå¡¢ÒºÌå»òÆøÌåÎïÖʰü¹üÖÆ³É΢СÄÒ×´Îï,±Ú³¬±¡¡¢ºñ½ö10nm¡£Villalobos-Hernan
dez ±¨µÀ[17]¶þÑõ»¯îÑÄÉÃ×½ºÄÒ»¯ºóSPFÏÔÖøÔö¼Ó£¬¿É¸ß´ï 50¡£Perugini [18]ÓÃÄÉÃ×ÔØÌåϵͳ¶Ô·Àɹ¼Á³É·Ö¹â½µ½â×÷ÓõÄÓ°Ïì½øÐÐÁËÏà¹ØÊµÑ飬½á¹ûʾ·Àɹ¼Á³É·ÖµÄ¹â½µ½â×÷ÓÃÔÚÄÉÃ×½ºÄÒ»¯ºóÓÉ52.3%½µµ½35.3%¡£Òò´Ë£¬ÔØÓз´Ê½2-ÒÒ»ù¼º»ù¼×Ñõ»ùÈâ¹ðËᣨtrans-2-ethylhexyl-p-meth-oxycinnamate£¬trans-EHMC£© µÄ¶à¾Û×óÓÒÐý±ûËá-ÒÒ´¼Ëá½»õ¥£¨poly-D,L-lactide-co-glycolide £¬PLGA £©ÄÉÃ×Á£Ìá¸ßÁË·Àɹ¼ÁµÄ¹âÎȶ¨ÐÔ¡£

4  ¿ª·¢ÄÉÃ×¼¼ÊõÔÚ·Àɹ»¯×±Æ·ÖÐÓ¦Óû¹Ðè×¢ÒâµÄ¼¸¸öÎÊÌâ
    ÈçÉÏËùÊö£¬ÄÉÃ×¼¼ÊõΪ·Àɹ»¯×±Æ·ÐÐÒµ´øÀ´¸ïÃüÐԵı仯¡£µ«MorganµÈ[19] Ìá³öÄÉÃ×¼¼ÊõÒ²Êǰѡ°Ë«Èн£¡±£¬ÌáÐÑÈËÃÇӦעÒâÕâÒ»¸ßм¼ÊõËù¾ßÓеÄDZÔÚΣÏÕ¡£ÄÉÃ×¼¼Êõ´øÀ´ÕâЩÓÅÁ¼ÌØÐÔµÄͬʱҲ¿ÉÄܶÔÉúÎïϵͳºÍ»·¾³²úÉúÓк¦Ó°Ïì,È磺¢ÙÄÉÃ×·ÛÓëÆ¤·ôÏàÈÝÐÔµÄÎÊÌ⣬»îÐÔÎïÖÊÄÉÃ×»¯ºóÓÐÒýÆðƤ·ô´Ì¼¤·´Ó¦ºÍÑ×Ö¢·´Ó¦µÄ¿ÉÄÜ;¢ÚÄÉÃ×½ºÄÒ»¯¿ÉÒÔÌá¸ßÔÚ¿ÕÆøºÍ¹âÖв»Îȶ¨µÄ³É·ÖÈçάAËáÀࡢάÉúËØEµÈµÄ¹âÎȶ¨ÐÔ£¬µ«ÈÔÓÐÖÂÆ¤·ô¹âÃôµÄ¿ÉÄÜ;¢ÛÄÉÃ×¼¼Êõʹ·Àɹ»¯×±Æ·µÄ»îÐԳɷÖÉøÍ¸µ½Æ¤·ôµÄÁ¿Ôö¶à¡¢Éî¶ÈÔö¼Ó£¬Òò´ËʹÓÃʱӦÊʵ±¿ØÖÆ»îÐԳɷֵÄÓÃÁ¿¡£Sayes µÈ[20]ÓÃÌåÍâʵÑé¼ì²â»îÐÔ´Ø£¨reactive species£¬RS£©À´ÆÀ¼Û·Àɹ»¯×±Æ·µÄϸ°û¶¾ÐÔ£¬ÔÚϸ°ûÅàÑøÖмì²âÄÉÃײÄÁ϶Ôϸ°ûµÄ¶¾ÐÔ£¬¹Û²ì½á¹û·¢ÏÖÄÉÃ×¶þÑõ»¯îÑÖ»ÓÐÔÚÏà¶Ô½Ï¸ßŨ¶ÈÏ£¨100 mg/ml £©²Å²úÉúϸ°û¶¾ÐÔºÍÑ×Ö¢·´Ó¦£¬ÇÒ³ÊÏÖʱЧºÍÁ¿Ð§¹ØÏµ¡£¹ÊĿǰ¹ú¼ÊÉÏÈÔ¼±Ðè¶ÔÄÉÃײÄÁϵݲȫÐÔ½øÐÐͳһµÄ¼ì²â¼°ÆÀ¼Û[21]¡£
  
[²Î¿¼ÎÄÏ×]
[1]Tuchinda C, Lim HW, Osterwalder U, et al. Novel emerging sunscreen technologies[J].Dermatol Clin,2006£¬24(1):105-117.
[2]Holzle E, Honigsmann H. UV-radiation--sources,wavelength, en-
vironment[J].Dtsch Dermatol Ges, 2005£¬3 Suppl 2:S3-10.  
[3]Bielecka GS, Klimowicz A, Zaluga E, et al. Protection of the skin from harmful ultraviolet radiation[J]. Ann Acad Med Stetin ,2005,51(2):33-37.
[4]Tsukahara K, Moriwaki S, Hotta M, et al. The effect of sunscreen on skin elastase activity induced by ultraviolet-A irradiation[J]. Biol Pharm Bull,2005,28(12):2302-2307.
[5]Azzarello LM, Dessureault S, Jacobsen PB, et al. Sun-protective behavior among individuals with a family history of melanoma[J]. Cancer Epidemiol Biomarkers Prev,2006£¬15(1):142-145.
[6]Draelos ZD. Sunscreens and hair photoprotection[J]. Dermatol Clin, 2006£¬24(1):81-84.
[7]Lin H, Datar RH.Medical applications of nanotechnology[J]. Natl Med J India.2006£¬19(1):27-32.
[8]Matsudai M, Hunt G. Nanotechnology and public health[J]. Nippon Koshu Eisei Zasshi, 2005£¬52(11):923-927.
[9]James H, Thrall MD. Nanotechnology and Medicine[J].Radiology,2004£¬230:315-318.
[10]Treye Thomas,Karluss Thomas, Nakissa Sadrieh,et al. Research Strategies for Safety Evaluation of Nanomaterials[J].Toxicological sciences, 2006£¬91(1):14-19.
[11]Kim H, Sigmund W. ZnO nanocrystals synthesized by physical vapor deposition[J]. J Nanosci Nanotechnol, 2004£¬4(3):275-278.
[12]Pan H, Zhu Y,Ni Z,et al. Optical and field emission properties of Zinc Oxide nanostructures[J]. J Nanosci Nanotechnol, 2005£¬5(10):1683-1687.
[13]Fan Z, Lu JG. Zinc oxide nanostructures: synthesis and properties[J].J Nanosci Nanotechnol, 2005£¬5(10):1561-1573.
[14]Althues H, Simon P, Philipp F,et al. Integration of zinc oxide nanoparticles into transparent poly(butanediolmonoacrylate) via photopolymerisation[J]. J Nanosci Nanotechnol,2006£¬6(2):409-413.
[15]Wissing SA, Muller RH. Cosmetic applications for solid lipid nanoparticles (SLN)[J].Int J Pharm,2003,254(1):65-68.
[16]Song C, Liu S. A new healthy sunscreen system for human: solid lipid nanoparticles as carrier for 3,4,5-trimethoxybenzoylc
hitin and the improvement by adding Vitamin E[J]. Int J Biol Macromol,2005,36(1-2):116-119.
[17]Villalobos-Hernandez JR.Novel nanoparticulate carrier system based on carnauba wax and decyl oleate for the dispersion of inorganic sunscreens in aqueous media[J]. Eur J Pharm Biopharm,2005£¬60(1):113-122.
[18]Perugini P, Simeoni S, Scalia S,et al. Effect of nanoparticle encapsulation on the photostability of the sunscreen agent, 2-ethylhexyl-p-methoxycinnamate[J]. Int J Pharm,2002,246(1-2):37-45.
[19]Kara Morgan.Development of a Preliminary Framework for Informing the Risk Analysis and Risk Management of Nanoparticles[J]. Risk Analysis,2005,25£¨6£©£º1621-1634.
[20]Christie Sayes, Rajeev Wahi, Preetha A,et al.Correlating Nanoscale Titania Structure with Toxicity: A Cytotoxicity and Inflammatory Response Study with Human Dermal Fibroblasts and Human Lung Epithelial Cells[J].Toxicological sciences,2006,92(1):174-185.
[21]Nel A, Xia T, Madler L,et al.Toxic potential of materials at the nanolevel[J].Science,2006£¬311(5761):622-627.
3Â¥2007-06-14 13:34:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wuhuiinciac

ľ³æ (ÖøÃûдÊÖ)

³¶µ°µ°³¤

ÄÉÃ×̼Ëá¸ÆÔÚÍ¿ÁÏÐÐÒµÖеÄÓ¦ÓÃÏÖ×´ÓëÕ¹Íû

berlin(½ð±Ò+0):½ð±ÒÀ´³Ù£¬ÐÖµÜÎð¹Ö£¬»¶Ó­Äã²ÎÓëµ½ÈÕ»¯°æ¿éµÄ½¨ÉèÖÐÀ´£¬Ð»Ð»°Â
ºÇºÇ,Â¥Ö÷,ÄãºÜÓд´Ò⣬ÎÒ¶¥Ò»¸ö£¡£¡
ÄÉÃ×̼Ëá¸ÆÔÚÍ¿ÁÏÐÐÒµÖеÄÓ¦ÓÃÏÖ×´ÓëÕ¹Íû
http://www.sciei.com/Article/write/chro/200703/Article_10281.html
Öйú»¯¹¤Íø2007Äê3ÔÂ13ÈÕ±¨µÀ£ºÄÉÃײÄÁÏÊÇÖ¸¾§ÌåÁ£¾¶ÎªÄÉÃ×¼¶µÄ¶à¾§Ìå²ÄÁÏ£¬¾ßÓÐС³ß´çÓë¸ßŨ¶È¾§½çÁ½¸öÖØÒªÌØÕ÷£¬Í¨³£´ó¾§ÌåµÄÁ¬ÐøÄÜ´ø·ÖÁѳɽӽü·Ö×Ó¹ìµÀµÄÄܼ¶£¬²úÉúÁËС³ß´çµÄÁ¿×ÓËíµÀЧӦ£¬Í¬Ê±ÓÉÓÚÆä¸ßŨ¶È¾§½ç¼°½çÃæÔ­×ÓÊÜÁ¦²»¾ùºâÐÔÔö¼Ó²úÉúÁ˽çÃæÐ§Ó¦£¬ÕâÁ½ÖÖЧӦµ¼Ö²ÄÁÏÔÚÁ¦Ñ§ÐÔÄÜ¡¢´ÅÐÔÄÜ¡¢¹âѧÐÔÄÜ¡¢µçÐÔÄܼ°ÈÈÁ¦Ñ§ÌØÕ÷·¢ÉúÍ»±ä¡£½«ÄÉÃײÄÁÏÓ¦ÓÃÓÚÍ¿ÁÏÖУ¬ÓÉÓÚ³ÉĤ»ùÁÏ¡¢ÑÕÌîÁϼ°Öú¼ÁµÈ·Ö×ÓÖдæÔÚ×ÅÖî¶àµÄ»îÐԵ㣬ÕâЩ»îÐÔµã¿ÉÄÜ»áÓëÄÉÃ×Á£×Ó±íÃæµÄ»îÐÔµãÖ®ÎÊ·¢ÉúÇ¿ÁÒµÄÏ໥×÷Ó㬴ӶøÓпÉÄÜÐγÉÖÂÃܶøÎȶ¨µÄÍ¿²ã£¬Ê¹Í¿Ä¤µÄÎïÀí»¯Ñ§ÐÔÄÜÏÔÖøÌá¸ß¡£Ì¼Ëá¸ÆÊÇÒ»ÖÖÎÞ¶¾¡¢Î޴̼¤¡¢ÎÞÆøÎ¶µÄ°×É«ÈíÖÊÌîÁÏ£¬ÔÚÍ¿ÁϹ¤ÒµÖУ¬ÆäÒ×ÓÚÓë¸÷Àà¾ÛºÏÎïÏàÈÝ£¬ÈÈÎȶ¨ÐԺã¬ÊÇ×î³£ÓõÄÔ­ÁÏÖ®Ò»£¬ÔÚ³ÉĤÎïÖÐÆð׏ǼÜ×÷Ó᣽üÄêÀ´Ëæ×ÅÄÉÃ×¼¼ÊõµÄÐËÆð£¬½«ÄÉÃ×̼Ëá¸ÆÓ¦ÓÃÓÚÍ¿ÁÏÖÐÒÔÆÚ¸ÄÉÆÍ¿ÁÏÐÔÄÜÊÇÍ¿ÁÏ½ç¹Ø×¢µÄÈÈÃÅ»°ÌâÖ®Ò»£¬ÓÈÆäÊǹúÄÚÖÚ¶àÍò¶Ö¼¶µÄÄÉÃ×̼Ëá¸ÆÉú²úÏߵĽ¨³É£¬¸üÊÇÆÈÇÐÐèҪѰÕÒ°üÀ¨Í¿ÁÏÔÚÄÚµÄһϵÁÐÁìÓòÖлñµÃÓ¦Óã¬È»¶øÄÉÃ×̼Ëá¸ÆÖ±½ÓÓ¦ÓÃÓÚÍ¿ÁÏÖУ¬´æÔÚÒÔÏÂȱÏÝ£º¿ÅÁ£±íÃæÄܸߣ¬´¦ÓÚÈÈÁ¦Ñ§²»Îȶ¨×´Ì¬£¬¼«Ò×Ížۣ»Ì¼Ëá¸Æ±íÃæÇ×Ë®ÊèÓÍ£¬¼«ÐԺܸߣ¬ÔÚÓлú½éÖÊÖÐÄÑÒÔ·ÖÉ¢£¬Óë»ùÁϵĽáºÏÁ¦²î£¬Ò×ÐγɽçÃæÈ±ÏÝ£¬µ¼ÖÂͿĤÐÔÄÜϽµ¡£[¿ÆÑÐÖйúhttp://www.SciEI.com]
[Ïà¹ØÁбí]http://www.SciEI.com/Article/write/chro/Index.html  


¡¡¡¡±¾ÎĽáºÏ¼¸ÄêÀ´×÷Õß¶ÔÄÉÃ×̼Ëá¸Æ¸´ºÏÍ¿ÁϵÄÑо¿£¬¶Ô¹úÄÚÍâÄÉÃ×̼Ëá¸Æ¸´ºÏÍ¿ÁϵÄÑо¿ÏÖ×´½øÐиÅÊö£¬Ï£ÍûÓÐÖúÓÚ¹úÄÚÄÉÃ×̼Ëá¸Æ¸´ºÏÍ¿ÁÏÑо¿µÄ½øÒ»²½É£¬ÎªÄÉÃ×̼Ëá¸Æ¸´ºÏÍ¿ÁϵIJúÒµ»¯Ñо¿Ìṩ½è¼ø¡£

¡¡¡¡1ÄÉÃ×̼Ëá¸Æ¿ÅÁ£µÄ±íÃæ¸ÄÐÔ

¡¡¡¡ÄÉÃ×̼Ëá¸Æ¿ÅÁ£Ó¦ÓÃÓÚÍ¿ÁÏÖУ¬ÒªÉæ¼°µ½ÄÉÃײÄÁÏÓë»ùÁϵÄÏàÈÝÐÔ£¬Í¿ÁϵijÉĤ»ùÁÏÓëËÜÁÏ¡¢Ï𽺵ȸ߾ÛÎïÔÚ¹ÙÄÜÍŵÄÖÖÀàÓëÊýÁ¿¡¢Ïà¶Ô·Ö×ÓÖÊÁ¿µÈ·½ÃæÃ÷ÏÔ²»Í¬£¬½ø¶øµ¼Ö¾ۺÏÎïµÄ±íÃæ¼«ÐÔ¼°ÓëÑÕÌîÁϵÄÏ໥×÷Ó÷½Ê½½ÔÓÐÇø±ð¡£ÒªÊ¹ÄÉÃ×̼Ëá¸Æ³É¹¦Ó¦ÓÃÓÚÍ¿ÁÏÖУ¬±ØÐë¶ÔÄÉÃ×̼Ëá¸Æ±íÃæ½øÐÐÌØÊâµÄ¸ÄÐÔ¡£

¡¡¡¡Æù½ñΪֹ£¬¶ÔÄÉÃ×̼Ëá¸ÆµÄ±íÃæ´¦Àí´ó¶à²ÉÓô«Í³µÄÎÞ»úÑÕÌîÁϵĴ¦Àí·½·¨£¬²ÉÓõĴ¦Àí¼Á¶àΪӲ֬Ëá¼°ÆäÑÎÀ࣬¸÷Àà±íÃæ»î¼ÁÓëżÁª¼ÁµÈ¡£ÕÅÉúÉúµÈÓÃÖ¬·¾ËáÄÆ´úÌæÖ¬·¾ËᣬÓÉÓÚ´¦ÀíʱͬʱͨÈ˶þÑõ»¯Ì¼£¬Êµ¼Ê°üĤÔÚ̼Ëá¸Æ±íÃæµÄÈÔÊÇÖ¬·¾ËᣬֻÊÇÖ¬·¾ËáÄÆÔÚË®ÖÐÀ©É¢Ê±½ÏÖ¬·¾ËáС£¬°üĤЧ¹ûÌá¸ß¡£µ«ÊÇ´Ó×÷ÕßÌṩµÄµç¾µÍ¼Æ¬¹Û²ì£¬·ÖÉ¢ÐÔ¸ÄÉÆ²¢²»ÏÔÖø¡£º«Ô¾Ð£¬µÈÖ±½ÓÔÚË®ÏàÖÐÀûÓÃÖ¬·¾Ëáͨ¹ýÇ¿ÖÆÈ黯µÄ·½·¨½øÐаü¸²£¬Ñо¿ÁËÔڸıäÖ¬·¾Ëá¼ÓÈëÁ¿Óëµ÷ÕûÈ黯Ìõ¼þʱ¶Ô°ü¸²ºóÄÉÃ×̼Ëá¸Æ»î»¯Ö¸ÊýµÄÓ°Ï죬·¢ÏÖ½¬ÁÏŨ¶ÈÔÚ9%×óÓÒ£¬Ö¬·¾ËáΪ2.5%ʱ£¬´¦ÀíºóµÄÄÉÃ×̼Ëá¸ÆµÄ»î»¯Ö¸Êý×î¸ß¡£Â½ºñ¸ù£¬µÈÔÚÑо¿²»Í¬¸ÄÐÔ¼Á¶ÔÄÉÃ×̼Ëá¸Æ½øÐбíÃæ´¦Àíʱ£¬·¢ÏÖ´¦Àí¼ÁµÄÄÚ¾ÛÁ¦Ô½Ð¡£¬¸ÄÐÔºó·ÖɢЧ¹ûÔ½ºÃ£¬¸ÄÐÔ¼ÁÔÚ¿ÅÁ£±íÃæÐγÉÍêÕûµ¥Îü¸½²ãʱ£¬ÆÁ±ÎµÄ±íÃæ»îÐÔµã×î¶à£¬¿ÅÁ£ÍžÛÏÖÏó×îÈõ£¬´ËʱµÄÎü¸½²ã¾ßÓйæÕûÖ±Á¢ÉìÕ¹¹¹Ï󣬿ÕÎÊλ×è´ó¡£¶ÅÕñϼ£¬µÈ¡§ÓÃÓлúËá°ü¸²ÄÉÃ×̼Ëá¸Æºó£¬·¢ÏÖÔÚÓлúÈܼÁÖеķÖÉ¢ÐÔ¸ÄÉÆÊ®·ÖÃ÷ÏÔ£¬Æä¸ÄÐÔºóµÄÄÉÃ×̼Ëá¸ÆÓÃÓÚ¾Û°±õ¥ÇåÆáÖУ¬Í¿Ä¤ÔÚ¹âÔó¡¢Á÷ƽÐÔ¡¢ÈáÈÍÐÔ¡¢Ó²¶ÈµÈ·½Ãæ¶¼µÃµ½¸ÄÉÆ¡£Erika FÈÏΪ£¬ÕâÖÖÐÔÄܵĸÄÉÆÔµÓÚÄÉÃ×̼Ëá¸Æ±íÃæ¸ÄÐÔ¼ÁÔÚÁ£×ÓÓë»ùÁÏÖ®¼äÐγÉÁËÒ»ÖÖÈÍÐÔÁ¬ÐøÄ¤£¬´ÙʹÄÉÃ×̼Ëá¸ÆÓë»ùÁϼ䷢ÉúÓ¦Á¦×ªÒÆËùÖ¡£±ûÏ©ËáÒ»ÂíÀ´ËáÒ»»ÇËá¹²¾ÛÎïµÄ°ü¸²£¬Ê¹ÄÉÃ×̼Ëá¸Æ±íÃæÐγɴó·Ö×ÓµÄÄÑÈÜÑΣ¬´¦Àí¼Á°ü¸²ÖÂÃÜÐÔÌá¸ß£¬¿ÅÁ£¼äÓÉÓÚµçºÉÓëλ×èË«ÖØ×÷Óã¬Îȶ¨ÐÔÔö¼Ó¡£

¡¡¡¡2ÄÉÃ×̼Ëá¸Æ¸´ºÏÍ¿ÁÏ

¡¡¡¡ÖÚËùÖªÖÜ£¬Ì¼Ëá¸Æ±¾Éí×÷ΪÌåÖÊÌîÁÏ£¬¹ã·ºÓ¦ÓÃÓÚ¸÷ÀàÍ¿ÁÏÖС£Ëü¿ÉÒԸıäÍ¿ÁϵÄÁ÷±äÐÔ¡¢Í¿²ãµÄÈÍÐÔ¡¢ÄÍË®ÐÔ¡¢ÄͺòÐÔ£¬½µµÍÍ¿²ãµÄ¼Ó¹¤³É±¾¡£Ó봫ͳµÄÖØ¸Æ»òÇá¸ÆÏà±È£¬ËäÈ»ÄÉÃ×̼Ëá¸ÆµÄ³É±¾´ó·ù¶ÈÉÏÉý£¬µ«½ÏÆäËûÆÕͨÑÕÌîÁÏÏà±ÈÈÔ´¦Óڽϵ͵ļÛ룬ÓÈÆäÊÇ̼Ëá¸ÆÄÉÃ×»¯ºó£¬ÆäÔÚÍ¿²ã²¹Ç¿ÐÔ¡¢Í¸Ã÷ÐÔ¡¢´¥±äÐÔ¡¢Á÷ƽÐԵȷ½ÃæËù´øÀ´µÄ±ä»¯£¬¸üÊÇÍ¿ÁÏÉú²úÆóÒµËù¹Ø×¢µÄÈȵ㡣

¡¡¡¡2.1½¨ÖþÍ¿ÁÏ

¡¡¡¡ÓÉÓÚ´æÔÚ¡°À¶ÒÆ¡±ÏÖÏó£¬ÔÚÈ齺ÆáÖпÉÒÔÆÁ±Î×ÏÍâ¹â£¬Æðµ½¸ôÈȵÄЧ¹û£¬Í¿²ãµÄÄÍÀÏ»¯ÐÔÄܵõ½ÁËÌá¸ß¡£½«ÄÉÃ×̼Ëá¸ÆÓ¦Óõ½ÍâǽͿÁÏÖУ¬Í¿²ãÕ¹ÏÖÇ¿Áҵġ°ÊèË®ÐÔ¡±£¬Í¿²ãµÄ¿¹ÁÑÇ¿¶È¡¢ÄÍÎÛȾÐÔ¾ùµÃµ½ÔöÇ¿H¡£

¡¡¡¡Ò»°ãÍ¿ÁÏÅä·½ÖУ¬¾ùº¬ÓÐÒ»¶¨Á¿µÄ¸ÕÐÔ¿ÅÁ££¬ÓеÄÅä·½Öк¬Á¿»¹Ï൱´ó£¬ÕâЩ¸ÕÐÔÁ£×ӵĴæÔڻᵼÖÂͿĤÖÐÓ¦Á¦¹ýÓÚ¼¯ÖУ¬Ê¹Ê÷Ö¬²úÉúÁÑÎÆ£¬ÄÉÃ×̼Ëá¸ÆµÄÒýÈ룬ʹ֮ÓëÊ÷Ö¬¼ä²úÉú¸ü¶àµÄ½Ó´¥¼¸ÂÊ£¬²úÉú¸ü¶àµÄ΢ÁÑÎÆ²¢ÒýÆðµ¯ÐÔÐα䣬½«¸ü¶àµÄ³å»÷ÄÜÁ¿×ª»¯ÎªÈÈÄÜÎüÊÕµô£¬´Ó¶øÌá¸ßÈÍÐÔ¡£Í¨¹ýÔÚ´«Í³µÄÈ齺ÆáÖÐÌí¼ÓÑÕÌîÁÏÁ¿2%¡«5%µÄ¾­ÌØÊâ¾ÛºÏÎï±íÃæ´¦ÀíµÄÄÉÃ×̼Ëá¸Æ£¬·¢ÏÖ²»½öÍ¿ÁϵÄÁ÷±äÐÔ¡¢¿ª¹ÞЧ¹ûµÃµ½¸ÄÉÆ£¬¸üΪ¾ªÑȵÄÊÇÄÍË®ÐÔ¡¢ÄÍÏ´Ë¢ÐÔ¡¢Ó²¶È¾ùµÃµ½´ó·ù¶ÈµÄÌá¸ß£¬ÇÒÄÍÏ´Ë¢ÐÔµÄÔö¼Ó³ÊÏÖµÄÊǼ¸ºÎ¼¶ÊýµÄÔö³¤¡£Í¨¹ýµç¾µ¡¢ºìÍâ¡¢ÈÈ·ÖÎöµÈ·ÖÎöÊֶζÔÍ¿²ã±íÃæ½á¹¹½øÐй۲죬·¢ÏÖÍ¿²ãÖв¢Ã»ÓÐÐµĻ¯Ñ§¼ü²úÉú£¬¶øÍ¿²ãÖоۺÏÎïµÄ½á¾§ÐÔ¡¢Í¿Ä¤µÄÖÂÃÜÐÔ¶¼µÃµ½Ã÷ÏԸĽø¡£Ä¿Ç°ÈÕ±¾µÄ°×ʯ¡¢Òâ´óÀûÎ÷Ä·µÈ¹«Ë¾Éú²úµÄÄÉÃ×̼Ëá¸Æ¾ùÖ÷ÒªÓÃÓÚ¸ÄÐÔË®ÐÔÈ齺ͿÁϵÄÐÔÄÜ¡£

¡¡¡¡2.2¾Û°±õ¥Í¿ÁÏ

¡¡¡¡¼Ö־奡§ÒÔÖ¬·¾ËáÑÎsA - 3Óë¾ÛºÏÎïR¡ªs¸ÄÐÔµÄÄÉÃ×CaCO3·ÖÉ¢¼ÓÈë¾Ûõ¥Ò»¾Û°±õ¥ÇåÆáÖУ¬Ëæ×żÓÈëÁ¿µÄ¸Ä±ä£¬Í¿ÁϵĴ¥±äÐÔÔö¼ÓÏÔÖø£¬¶øÒÔÖ¬·¾ËáÑÎsA - 3Óë¾ÛºÏÎïR¡ªs¸ÄÐÔµÄÄÉÃ×CaCO3¶ÔÍ¿ÁϵĻúеÐÔÄÜ¡¢Á÷ƽÐÔ¡¢¹âÔóµÈ·½ÃæµÄÓ°Ïì¾ù½Ïδ¸ÄÐÔµÄÄÉÃ×CaCO3¾ßÓÐÓÅÊÆ¡£

¡¡¡¡×ÞµÂÈÙÀûÓöËôÇ»ù¾Û¶¡¶þÏ©(HTPB)¡¢¶àÒìÇèËáõ¥¡¢ÄÉÃ×CaCO 3µÈÔ­ÁÏ£¬²ÉÓÃÈȾۺϰü¸²¹¤ÒÕ£¬ÖƳɶ˻ùΪ¡ªNCOµÄµ¯ÐÔÔ¤¾ÛÎャÁÏ£¬ÔÚÒ»¶¨µÄ·¶Î§ÄÚ£¬Ëæ×ÅÄÉÃ×̼Ëá¸ÆÔÚÅä·½ÖбÈÀýµÄÔö¼Ó£¬ð¤¶ÈÖð²½Ìá¸ß£¬¹Ì»¯ºóͿĤÀ­ÉìÇ¿¶ÈÓë¶ÏÁÑÉ쳤ÂʾùÓÐËùÌá¸ß£¬Í¿ÁÏÓë½ðÊôÖ®¼äµÄÕ³½áÇ¿¶È(¿¹À­Ç¿¶ÈÓ뿹¼ôÇ¿¶È)ÒàÓÐËù¸ÄÉÆ£¬¶ø¼ÓÁ¿¹ý´ó£¬ÐÔÄÜ·´¶ø³ÊϽµÇ÷ÊÆ¡£×÷ÕßÈÏΪÕâÊÇÄÉÃ×Á£×Ó±¾ÉíÐÔÄܵľÖÏÞÐÔËùÖ£¬ËüÖ»ÄܶԱ¾Éí¾ßÓÐÒ»¶¨ÈÍÐԵĻùÌå²ÅÓÐÔöÈÍ×÷Óá£

¡¡¡¡2.3ÆäËûÍ¿ÁÏ

¡¡¡¡ÉϺ£Ñ©ÃÀ¾«Ï¸»¯¹¤³§ÀûÓÃÉú²úµÄxm302ÐÍÄÉÃ×̼Ëá¸ÆÓ¦ÓÃÓÚÉϺ£´óÖڽγµPVC³µµ×·Àʯ»÷Í¿ÁÏ£¬¸ÃÍ¿ÁϾßÓÐÈçÏÂÐÔÄÜ£ºÕ¹¿í²£Á§»¯×ª±äÇø·¶Î§£¬³ÊÏֽϸß×èÄáÖµ£¬Á¼ºÃµÄ´¥±äÐÔ£¬½ÏÀíÏëµÄ¿¹ÕÅÇ¿¶È¡¢¶ÏÁÑÉ쳤ÂÊÒÔ¼°Çü·þÓ¦Á¦¡£×÷ÕßÈÏΪÕâÊÇÓÉÓÚ·ÖÉ¢ÓÚÍ¿ÁÏÖеÄÄÉÃ×̼Ëá¸Æ¿ÅÁ£¼«ÆäϸС£¬ÔÚÒ»¶¨µÄÌå»ý·ÖÂÊÏ£¬Á£×ÓÊý¼±¾çÔö¼Ó£¬Á£×Ӽ䯽¾ù¾àÀëËõС£¬ÈκÎÁ½¸öÁ£×Ó½øÈëÏ໥ÎüÒýÇøµÄ»ú»áѸËÙÔö¼Ó£¬µ¼ÖÂð¤¶ÈÔö¼Ó£¬²ÄÁÏÊÜÓ¦Á¦×÷ÓÃʱ£¬´óÁ¿¿ÅÁ£ÖʵãÖ®¼äµÄ»¬¶¯ÎüÒý½Ï¶àµÄ³å»÷ÄÜ£¬´Ó¶øÌåÏÖÔڽϿíµÄζȷ¶Î§ÄÚÓнϸߵÄ×èÄáÖµ£¬¶øÄÉÃ×̼Ëá¸Æ±íÃæµÄ´¦Àí¼Á²ã¿ÉÓÐЧµØÔÚÓлúÎïÓëÎÞ»úÎï½çÃæÇø´«µÝºÍËɳ۽çÃæÉϵÄÓ¦Á¦£¬¸üºÃµØÎüÊÕÓë·ÖÉ¢³å»÷ÄÜ¡£¿¼Âǵ½´¦Àí¼Á±¾ÉíËù¾ßÓеĿÉÄÓÐÔ£¬´Ó¶øÌá¸ßÁËͿĤµÄÁ¦Ñ§Ç¿¶È¡£

¡¡¡¡Ð¤ÏÉÓ¢µÈÔÚÀûÓö÷ƽ¹ãƽ»¯¹¤Éú²úµÄÄÉÃ×̼Ëá¸ÆÅäÖÆµÄÔìֽͿÁÏÖз¢ÏÖ£¬¼ÓÈëÉÙÁ¿µÄÄÉÃ×̼Ëá¸Æ(ÑÕÌîÁÏ×ÜÁ¿µÄ5%)£¬¿ÉÓÐЧµØÌá¸ßÍ¿ÁÏð¤¶È£¬µ«Ëæ×ÅÄÉÃ×̼Ëá¸ÆÓÃÁ¿µÄÔö¼Ó(ÑÕÌîÁϵÄ10%)£¬ð¤¶È·´¶øÏ½µ¡£IGT¿¹ÕÅëÀ­Ç¿¶ÈÖµÒàÊÇËæÄÉÃ×̼Ëá¸ÆÓÃÁ¿µÄÔö¼Ó£¬³ÊÏÖÏÈÉÏÉýºóϽµµÄÇ÷ÊÆ£¬ÁíÍ⣬ÄÉÃ×̼Ëá¸Æ¶ÔÖ½ÕŵÄÓÍÄ«ÎüʪÐÔ¡¢Í¿²ãµÄÇ¿¶ÈÓëÆ½»¬¶ÈµÈ¾ùÓиĽø

¡¡¡¡3½áÓï

¡¡¡¡ËäÈ»ÄÉÃ×̼Ëá¸ÆÔÚ½üÄêÄÚÒÑʵÏÖÁ˲úÒµ»¯£¬µ«ÄÉÃ×̼Ëá¸ÆµÄÓ¦ÓÃÉÐÖ÷Òª¼¯ÖÐÔÚPVC¡¢PP£¯PEµÈËÜÁÏÖУ¬¶øÔÚÍ¿ÁÏÖеÄÓ¦ÓÃÑо¿»¹ÊǺܲ»³ÉÊ죬¸ü̸²»ÉÏ´óÃæ»ýÍÆ¹ãÁË¡£×÷ÕßÈÏΪ£¬Òª½â¾öÄÉÃ×̼Ëá¸ÆÔÚÍ¿ÁÏÖеÄÓ¦Óü¼ÊõÎÊÌ⣬±ØÐë¶ÔÒÔϼ¸¸ö·½Ã湤×÷½øÐÐÇ¿»¯¡£

¡¡¡¡(1)ÄÉÃ×̼Ëá¸Æ´¦Àí¼ÁµÄÑ¡Ôñ¼°´¦Àí¹¤ÒÕ

¡¡¡¡±íÃæ´¦Àí¼ÁÔÚ³ÉĤ»ùÁÏÓëÎÞ»ú·ÛÌåÖ®¼äÆðÁ¬½Ó×÷Ó㬴¦Àí¼ÁµÄÐÔÄÜÖ±½ÓÓ°ÏìÍ¿ÁϵÄÐÔÄÜ¡£±ÊÕßÔøÀûÓÃÓ²Ö¬ËᡢijЩîÑËáõ¥ÓëÓлú¹èżÁª¼ÁµÈ´¦ÀíµÄÄÉÃ×̼Ëá¸ÆÓ¦ÓÃÓÚ»·ÑõÍ¿ÁÏ¡¢ÈÈËÜÐÔ±ûÏ©ËáÍ¿ÁÏ¡¢±½±ûÈ齺ͿÁÏ£¬·¢ÏÖÍ¿ÁÏÔÚ¼ÓÈëÄÉÃ×̼Ëá¸ÆºóÐÔÄܶà³ÊϽµÇ÷ÊÆ£¬¶øÀûÓÃ×Ô¼ººÏ³ÉµÄ¶à¹ÙÄܶȾۺÏÎï´¦ÀíµÄÄÉÃ×̼Ëá¸ÆÈ´ÄÜÃ÷ÏÔ¸ÄÉÆÍ¿²ãµÄһϵÁÐÐÔÄÜÈçÁ¦Ñ§Ç¿¶È¡¢ÄÍË®ÐԵȡ£ËµÃ÷²»Í¬µÄ´¦Àí¼ÁËäÈ»ÄÜ´ïµ½´Ù½øÄÉÃ×̼Ëá¸Æ·ÖÉ¢µÄÄ¿µÄ£¬µ«ÓÉÓÚÓë»ùÁϵÄÏ໥×÷Óò»Í¬£¬½ø¶ø¶ÔÐÔÄܵÄÓ°Ï첻ͬ£¬¶øÐ¡·Ö×ӵıíÃæ´¦Àí¼Á¾ßÓÐÇ¨ÒÆÐÔ£¬Ê¹Ö®²»ÀûÓÚÍ¿ÁÏÐÔÄܵĸÄÉÆ¡£

¡¡¡¡(2)Ç¿»¯ÄÉÃ×CaCO 3ÔÚÍ¿ÁÏÖеÄÓ¦Óûù´¡Ñо¿

¡¡¡¡ÄÉÃײÄÁÏÓë³ÉĤÎï¡¢ÆäËûÔ­²ÄÁϵÄÏ໥×÷ÓÃÐÎʽ¡¢ÄÉÃ×̼Ëá¸ÆÔÚÍ¿²ãÖеķֲ¼×´Ì¬µÈ¶ÔÍ¿²ãµÄÐÔÄÜÓÐÖØÒªÓ°Ï죬±ØÐëÁ˽âÄÉÃ×̼Ëá¸ÆÔÚ²»Í¬ÌåϵÖеÄÏ໥×÷Óã¬Ñо¿ÕâЩÏ໥×÷Ó㬿ÉÒÔ½èÖúÓÚһЩÏÖ´ú½á¹¹·ÖÎö·½·¨£¬Èç̽Õë¡¢µç¾µ¡¢ºìÍâµÈ¡£ÖªµÀÄÉÃ×̼Ëá¸ÆÈçºÎ¸Ä±äÍ¿²ãµÄ΢¹Û½á¹¹£¬½«ÓÐÖúÓÚÄÉÃ×̼Ëá¸ÆÒ»¸´ºÏÍ¿ÁϵÄÅä·½Éè¼Æ¡£
-
4Â¥2007-06-14 14:12:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 329Çóµ÷¼Á +5 ÏëÉÏѧ߹߹ 2026-03-19 5/250 2026-03-19 23:56 by 23Postgrad
[¿¼ÑÐ] 307Çóµ÷¼Á +9 ÀäóÏ123 2026-03-17 9/450 2026-03-19 22:44 by ѧԱ8dgXkO
[¿¼ÑÐ] Áº³ÉΰÀÏʦ¿ÎÌâ×é»¶Ó­ÄãµÄ¼ÓÈë +9 һѼѼӴ 2026-03-14 11/550 2026-03-19 17:22 by £¡±¾°µÒ»´Î£¡
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +4 z1z2z3879 2026-03-14 6/300 2026-03-19 17:18 by fei626-918
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷°²½»Í¨´óѧ²ÄÁϹ¤³Ìרҵ 282·ÖÇóµ÷¼Á +5 ·ãÇÅZL 2026-03-18 7/350 2026-03-19 14:52 by ¹¦·ò·è¿ñ
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +7 Ϊѧ666 2026-03-16 7/350 2026-03-19 14:48 by ¾¡Ë´Ò¢1
[¿¼ÑÐ] 304Çóµ÷¼Á +3 ÂüÊâ2266 2026-03-18 3/150 2026-03-19 14:42 by peike
[¿¼ÑÐ] Ò»Ö¾Ô¸ Î÷±±´óѧ £¬070300»¯Ñ§Ñ§Ë¶£¬×Ü·Ö287£¬Ë«·ÇÒ»±¾£¬Çóµ÷¼Á¡£ +3 ³¿»èÏßÓëÐǺ£ 2026-03-19 3/150 2026-03-19 13:36 by houyaoxu
[¿¼ÑÐ] Ò»Ö¾Ô¸Öк£Ñó²ÄÁϹ¤³Ìר˶330·ÖÇóµ÷¼Á +7 С²Ä»¯±¾¿Æ 2026-03-18 7/350 2026-03-19 10:46 by Linda Hu
[¿¼ÑÐ] Ò»Ö¾Ô¸Ìì´ó²ÄÁÏÓ뻯¹¤£¨085600£©×Ü·Ö338 +5 ²Ì´óÃÀÅ® 2026-03-13 5/250 2026-03-19 10:44 by ÊÇСÁõѽ¡«
[¿¼ÑÐ] 303Çóµ÷¼Á +4 î£08 2026-03-17 6/300 2026-03-18 11:01 by Iveryant
[¿¼ÑÐ] 0703»¯Ñ§Çóµ÷¼Á ×Ü·Ö331 +3 ZY-05 2026-03-13 3/150 2026-03-18 10:58 by macy2011
[¿¼ÑÐ] 293Çóµ÷¼Á +11 zjlµÄºÅ 2026-03-16 16/800 2026-03-18 08:10 by zhukairuo
[¿¼ÑÐ] 326Çóµ÷¼Á +5 Éϰ¶µÄСÆÏ 2026-03-15 6/300 2026-03-17 17:26 by ruiyingmiao
[¿¼ÑÐ] 11408 Ò»Ö¾Ô¸Î÷µç£¬277·ÖÇóµ÷¼Á +3 zhouzhen654 2026-03-16 3/150 2026-03-17 07:03 by laoshidan
[¿¼ÑÐ] 304Çóµ÷¼Á +5 ËØÄê¼ÀÓï 2026-03-15 5/250 2026-03-16 17:00 by ÎҵĴ¬Îҵĺ£
[¿¼ÑÐ] 304Çóµ÷¼Á +3 ÂüÊâ2266 2026-03-14 3/150 2026-03-16 16:39 by houyaoxu
[¿¼ÑÐ] 0703 ÎïÀí»¯Ñ§µ÷¼Á +3 ÎÒ¿ÉÒÔÉϰ¶µÄ¶Ô 2026-03-13 5/250 2026-03-16 10:50 by ÎÒ¿ÉÒÔÉϰ¶µÄ¶ÔÂ
[¿¼ÑÐ] 297Çóµ÷¼Á +4 ѧº£Æ¯²´ 2026-03-13 4/200 2026-03-14 11:51 by ÈÈÇéɳĮ
[¿¼ÑÐ] ÕÐÊÕ0805£¨²ÄÁÏ£©µ÷¼Á +3 18595523086 2026-03-13 3/150 2026-03-14 00:33 by 123%¡¢
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û